arrow_back Back to App

Glioblastoma Awareness Day: Boosting Knowledge and Research Support

The U.S. Senate has designated July 16, 2025, as Glioblastoma Awareness Day. This aims to increase public understanding of this aggressive brain cancer, which affects thousands annually, and to highlight the urgent need for further research and improved treatments. The designation encourages support for patients and their families, as well as investment in therapeutic advancements.
Key points
Designation of July 16, 2025, as Glioblastoma Awareness Day to raise awareness about this deadly disease.
Encouragement for increased public awareness of glioblastoma, its symptoms, and treatment challenges.
Support for research into new treatments and diagnostic methods, including biomarker testing, to improve patient prognosis.
Honoring individuals affected by glioblastoma and supporting their families and caregivers.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 119_SRES_285
Sponsor: Sen. Graham, Lindsey [R-SC]
Process start date: 2025-06-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating July 16, 2025, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_SRES_285.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-06-17.

What are the main provisions?

Key points include:

  • Designation of July 16, 2025, as Glioblastoma Awareness Day to raise awareness about this deadly disease.
  • Encouragement for increased public awareness of glioblastoma, its symptoms, and treatment challenges.
  • Support for research into new treatments and diagnostic methods, including biomarker testing, to improve patient prognosis.
  • Honoring individuals affected by glioblastoma and supporting their families and caregivers.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Graham, Lindsey [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3442; text: CR S3441)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health